News Release

Advisory Board meets

Date: 2000/05/19

International Wex Technologies Inc. (the "company") is pleased to announce that the first meeting of our newly appointed Advisory Board will take place on Tuesday and Wednesday, May 23rd and 24th at our Vancouver Head office. All the advisors to the company arrive in Vancouver this weekend. Mr. Frank Shum, the C.E.O. has arrived in Vancouver to attend this important symposium.

Tetrodin(HT) has been developed by the company primarily as a treatment for the symptoms associated with withdrawal from all opiate addictions such as morphine, opium, heroin and methadone. It is a non-narcotic pharmaceutical that has proven to be safe and effective and functions well in both primary withdrawal treatment and abstinence maintenance (longer term use) of drug addiction. The company has also begun tests on the usage of Tetrodin(HT) as a potent analgesic.

For additional information on Tetrodin(HT), view the IWT website at http://www.wextech.ca or call Howard Milne , V. P. Shareholder Communications, at 604-683-8880 or 1-800-722-7549

Per: Donna Shum, Corporate Secretary